Search research articles
Contact Us
Filters
Showing results (41-50 of 255) with videos related to
Page
of 26
Sort By:
Journal of Clinical and Experimental Neuropsychology
|
February 18, 2006
The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome
Richard S E Keefe, Margaret Poe, Trina M Walker, et al.
Schizophrenia Research
|
October 22, 2017
Genetic correlates of insight in schizophrenia
Rose Mary Xavier, Allison Vorderstrasse, Richard S E Keefe, et al.
The International Journal of Neuropsychopharmacology
|
March 17, 2018
A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction
Richard S E Keefe, George Nomikos, Wei Zhong, et al.
Asian Journal of Psychiatry
|
June 1, 2017
Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia
Shahrzad Mazhari, Ali R Ghafaree-Nejad, Somayeh Soleymani-Zade, et al.
Molecular Psychiatry
|
April 19, 2017
The joint impact of cognitive performance in adolescence and familial cognitive aptitude on risk for major psychiatric disorders: a delineation of four potential pathways to illness
K S Kendler, H Ohlsson, R S E Keefe, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 18, 2015
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
Atul R Mahableshwarkar, John Zajecka, William Jacobson, et al.
Brain Sciences
|
February 25, 2023
Impact of Cognitive Impairments on Health-Related Quality of Life in Schizophrenia
Gurpreet Rekhi, Young Ern Saw, Keane Lim, et al.
Psychological Medicine
|
March 6, 2023
Risk for psychiatric and substance use disorders as a function of transitions in Sweden's public educational system: a national study
Kenneth S Kendler, Richard S E Keefe, Henrik Ohlsson, et al.
The Journal of Clinical Psychiatry
|
April 21, 2004
Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness
Philip D Harvey, Michael F Green, Richard S E Keefe, et al.
Schizophrenia Research
|
February 1, 2011
Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone
Philip D Harvey, Masaaki Ogasa, Josephine Cucchiaro, et al.
Page
of 26
Search research articles
Search
Showing results (41-50 of 255) with videos related to
Sort By:
Page
of 26
Journal of Clinical and Experimental Neuropsychology
|
February 18, 2006
The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome
Richard S E Keefe, Margaret Poe, Trina M Walker, et al.
Schizophrenia Research
|
October 22, 2017
Genetic correlates of insight in schizophrenia
Rose Mary Xavier, Allison Vorderstrasse, Richard S E Keefe, et al.
The International Journal of Neuropsychopharmacology
|
March 17, 2018
A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction
Richard S E Keefe, George Nomikos, Wei Zhong, et al.
Asian Journal of Psychiatry
|
June 1, 2017
Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia
Shahrzad Mazhari, Ali R Ghafaree-Nejad, Somayeh Soleymani-Zade, et al.
Molecular Psychiatry
|
April 19, 2017
The joint impact of cognitive performance in adolescence and familial cognitive aptitude on risk for major psychiatric disorders: a delineation of four potential pathways to illness
K S Kendler, H Ohlsson, R S E Keefe, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 18, 2015
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
Atul R Mahableshwarkar, John Zajecka, William Jacobson, et al.
Brain Sciences
|
February 25, 2023
Impact of Cognitive Impairments on Health-Related Quality of Life in Schizophrenia
Gurpreet Rekhi, Young Ern Saw, Keane Lim, et al.
Psychological Medicine
|
March 6, 2023
Risk for psychiatric and substance use disorders as a function of transitions in Sweden's public educational system: a national study
Kenneth S Kendler, Richard S E Keefe, Henrik Ohlsson, et al.
The Journal of Clinical Psychiatry
|
April 21, 2004
Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness
Philip D Harvey, Michael F Green, Richard S E Keefe, et al.
Schizophrenia Research
|
February 1, 2011
Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone
Philip D Harvey, Masaaki Ogasa, Josephine Cucchiaro, et al.
Page
of 26